Palladium Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $20.2M | Sell |
243,482
-6,785
| -3% | -$535K | 0.88% | 35 |
|
|
2021
Q4 | $19.4M | Buy |
250,267
+571
| +0.2% | +$45.5K | 0.79% | 40 |
|
|
2021
Q3 | $18.8M | Buy |
249,696
+39,308
| +19% | +$2.99M | 0.85% | 38 |
|
|
2021
Q2 | $16.4M | Sell |
210,388
-9,474
| -4% | -$705K | 0.77% | 41 |
|
|
2021
Q1 | $16.2M | Sell |
219,862
-807
| -0.4% | -$59.5K | 0.8% | 40 |
|
|
2020
Q4 | $17.2M | Buy |
220,669
+9,342
| +4% | +$714K | 0.95% | 32 |
|
|
2020
Q3 | $16.7M | Buy |
211,327
+4,704
| +2% | +$368K | 1.06% | 27 |
|
|
2020
Q2 | $15.2M | Buy |
206,623
+21,293
| +11% | +$1.6M | 1.04% | 24 |
|
|
2020
Q1 | $13.6M | Buy |
185,330
+37,280
| +25% | +$2.93M | 1.13% | 22 |
|
|
2019
Q4 | $12.8M | Buy |
148,050
+61,809
| +72% | +$5.08M | 0.83% | 34 |
|
|
2019
Q3 | $5.84M | Buy |
86,241
+2,875
| +3% | +$230K | 0.41% | 67 |
|
|
2019
Q2 | $6.67M | Buy |
83,366
+1,797
| +2% | +$138K | 0.46% | 63 |
|
|
2019
Q1 | $6.47M | Sell |
81,569
-3,071
| -4% | -$230K | 0.47% | 65 |
|
|
2018
Q4 | $6.17M | Sell |
84,640
-2,854
| -3% | -$201K | 0.49% | 63 |
|
|
2018
Q3 | $5.92M | Buy |
87,494
+1,432
| +2% | +$91.2K | 0.4% | 68 |
|
|
2018
Q2 | $4.99M | Sell |
86,062
-2,230
| -3% | -$126K | 0.36% | 72 |
|
|
2018
Q1 | $4.59M | Sell |
88,292
-4
| -0% | -$216 | 0.34% | 76 |
|
|
2017
Q4 | $4.74M | Buy |
88,296
+136
| +0.2% | +$7.54K | 0.34% | 77 |
|
|
2017
Q3 | $5.39M | Sell |
88,160
-695
| -0.8% | -$42.1K | 0.41% | 64 |
|
|
2017
Q2 | $5.43M | Sell |
88,855
-1,553
| -2% | -$94.5K | 0.43% | 64 |
|
|
2017
Q1 | $5.48M | Sell |
90,408
-2,085
| -2% | -$126K | 0.44% | 63 |
|
|
2016
Q4 | $5.2M | Sell |
92,493
-2,415
| -3% | -$141K | 0.44% | 64 |
|
|
2016
Q3 | $5.65M | Sell |
94,908
-975
| -1% | -$57K | 0.49% | 60 |
|
|
2016
Q2 | $5.27M | Sell |
95,883
-4,339
| -4% | -$231K | 0.48% | 61 |
|
|
2016
Q1 | $5.06M | Sell |
100,222
-3,633
| -3% | -$178K | 0.46% | 63 |
|
|
2015
Q4 | $5.23M | Sell |
103,855
-1,336
| -1% | -$67.4K | 0.48% | 64 |
|
|
2015
Q3 | $4.96M | Sell |
105,191
-2,871
| -3% | -$153K | 0.49% | 64 |
|
|
2015
Q2 | $5.87M | Sell |
108,062
-4,738
| -4% | -$266K | 0.52% | 64 |
|
|
2015
Q1 | $6.19M | Sell |
112,800
-2,276
| -2% | -$129K | 0.53% | 65 |
|
|
2014
Q4 | $6.24M | Sell |
115,076
-3,154
| -3% | -$176K | 0.54% | 61 |
|
|
2014
Q3 | $6.69M | Sell |
118,230
-1,301
| -1% | -$73.1K | 0.6% | 57 |
|
|
2014
Q2 | $6.6M | Buy |
119,531
+8,421
| +8% | +$459K | 0.59% | 57 |
|
|
2014
Q1 | $6.02M | Sell |
111,110
-146
| -0.1% | -$7.56K | 0.55% | 59 |
|
|
2013
Q4 | $5.31M | Sell |
111,256
-14,698
| -12% | -$672K | 0.5% | 65 |
|
|
2013
Q3 | $5.72M | Sell |
125,954
-60
| -0% | -$2.74K | 0.58% | 57 |
|
|
2013
Q2 | $5.59M | Buy |
+126,014
| New | +$5.63M | 0.59% | 53 |
|
Other funds holding MRK
Palladium Partners's MRK Position: Q1 2022 in Review
Palladium Partners reduced its Merck (MRK) stake by 2.7% in Q1 2022, selling an estimated $535K and leaving 243,482 shares worth $20.2M. The position accounts for 0.88% of the portfolio, ranked #35.
Palladium Partners first reported a position in MRK in Q2 2013 and has held it in 36 quarters since. 2,953 funds tracked by Wall St. Rank hold MRK as of Q1 2022.
- Palladium Partners held 243,482 shares of Merck worth $20.2M as of Q1 2022.
- Palladium Partners sold 6,785 Merck shares in Q1 2022, an estimated $535K.
- Merck made up 0.88% of Palladium Partners's portfolio in Q1 2022, its #35 holding.
- Palladium Partners first reported a position in Merck in Q2 2013 and has held it in 36 quarters since.
- 2,953 funds tracked by Wall St. Rank held Merck as of Q1 2022.
Based on Palladium Partners's 13F filing for Q1 2022, filed 26 Apr 2022.